Simplify Logo

Full-Time

Associate Director

Fp&a

Posted on 12/13/2023

Tessera Therapeutics

Tessera Therapeutics

201-500 employees

Develops gene writing genome engineering technology

Data & Analytics
Hardware
Biotechnology
Healthcare

Senior, Expert

Cambridge, MA, USA

Category
Finance & Banking
Required Skills
Communications
SAP Products
Requirements
  • Bachelor's degree in Finance or Accounting
  • 12 years of business experience, minimum of 6 years in FP&A roles
  • Strong interpersonal and communication skills
  • Ability to work independently and manage multiple projects simultaneously
  • Excellent problem-solving and analytical skills
  • Critical thinking capability
  • Ability to design systems and automate reporting and analysis
  • High self-motivation and commitment to personal and team growth
  • Understanding of valuation and modeling concepts
Responsibilities
  • Lead corporate-wide budgeting and planning processes
  • Lead month-end close and reporting activities
  • Monitor performance vs. budget and effect interventions with management
  • Collaborate with Senior Director, Strategic and Corporate FP&A
  • Support financial approval, governance, and decision-making processes
  • Administrate financial planning and reporting system
  • Develop and implement enhancements to financial planning, reporting, and enterprise systems
  • Analyze financial data to identify emerging trends and assess risks
  • Potential for business partnering including planning, reporting, and strategic analyses
Desired Qualifications
  • Advanced degree in Accounting, Finance, or another business concentration
  • Experience managing direct reports
  • Hands-on experience with Adaptive Planning, SAP, and Coupa
  • Experience in the Pharmaceutical, Biotechnology, and/or Life Science sectors
  • Advanced programming and automation skills
  • Knowledge of best practices in large finance departments and organizations

Tessera Therapeutics is pioneering Gene Writing™, a new genome engineering technology that writes therapeutic messages into the genome to treat diseases at their source. They are focused on expanding possibilities in genetic medicine through tissue-targeted non-viral delivery technology, addressing major unmet medical needs with potentially curative and accessible therapies.

Company Stage

Series C

Total Funding

$581.7M

Headquarters

Cambridge, Massachusetts

Founded

2018

Growth & Insights
Headcount

6 month growth

-3%

1 year growth

0%

2 year growth

39%
INACTIVE